Yigit Taha OZTURK 
The financial playbook of biotech firms is undergoing a transformation. No longer content with traditional assets, companies are now turning to digital currencies like Bitcoin to diversify their portfolios and hedge against currency depreciation.
Quantum Biopharma, a Canadian biotechnology company, has announced the purchase of $1 million in Bitcoin and other cryptocurrencies. According to a press release dated May 19, this move brings the firm’s total crypto holdings to approximately $4.5 million.
A Crypto Treasury Strategy Emerges in Biotech
The company also revealed plans to stake a portion of its digital assets to generate additional revenue. According to management, this strategy aims to provide returns for shareholders and act as a hedge against the weakening Canadian dollar.
You Might Be Interested In: Elon Musk Talks About the Name of a New Memecoin!
Following the announcement, shares of Quantum Biopharma (QNTM) surged by around 25%, reflecting investor optimism toward the firm’s crypto-focused financial strategy.
Biotech Companies Turning to Bitcoin
Quantum is part of a growing trend among healthcare companies embracing Bitcoin as a strategic asset. Back in March, Atai Life Sciences, a NASDAQ-listed biotech firm, unveiled plans to purchase $5 million worth of Bitcoin. Its founder, Christian Angermayer, stated, “Bitcoin should be part of any corporate treasury—especially in the biotech sector.”
On May 16, Basel Medical Group, a Singapore-based healthcare provider, disclosed its intent to buy $1 billion in Bitcoin. However, unlike Quantum, Basel’s stock took a significant hit after the announcement.
As of May 19, corporate treasuries collectively hold over $83 billion in Bitcoin, according to BitcoinTreasuries.NET. Public companies now rank as the second-largest institutional holders of Bitcoin, trailing only exchange-traded funds (ETFs).
According to Fidelity Digital Assets, Bitcoin can serve as a “valuable hedge against growing fiscal deficits, currency debasement, and geopolitical risks.”
You can also freely share your thoughts and comments about the topic in the comment section. Additionally, don’t forget to follow us on our Telegram, YouTube, and Twitter channels for the latest news and updates.